ZFIN ID: ZDB-TALEN-150403-6
TALEN Name: TALEN4-flt4
Target: flt4 (1)
Source:
Target Sequence 1:
5' - CTTCATAACAGACTCT - 3'
   
Select Sequence Analysis Tool

Target Sequence 2:
5' - CTGAAACCAGACATGGT - 3'
   
Select Sequence Analysis Tool

  (Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.)
TARGET LOCATION
No data available
CONSTRUCTS WITH SEQUENCES FROM TALEN4-flt4 No data available
GENOMIC FEATURES CREATED WITH TALEN4-flt4
Genomic Feature Affected Genomic Regions    
um131 flt4    
GENE EXPRESSION
Gene expression in Wild Types + TALEN4-flt4 No data available
PHENOTYPE
Phenotype resulting from TALEN4-flt4
No data available

Phenotype of all Fish created by or utilizing TALEN4-flt4
Phenotype Fish Conditions Figures
posterior cardinal vein flt4 expression decreased amount, abnormal flt4um131/um131 standard conditions Fig. 1 with image from Shin et al., 2016
intersegmental vein decreased amount, abnormal flt4um131/um131 standard conditions Fig. 3 with image from Shin et al., 2016
endothelial cell flt4 expression decreased amount, abnormal flt4um131/um131 standard conditions Fig. 1 with image from Shin et al., 2016
posterior cardinal vein vascular sprouts Ab2-tek labeling absent, abnormal flt4um131/um131 standard conditions Fig. 3 with image from Shin et al., 2016
eye anatomical region edematous, abnormal flt4um131/um131 standard conditions Fig. 6 with image from Shin et al., 2016
intersegmental artery increased amount, abnormal flt4um131/um131 standard conditions Fig. 3 with image from Shin et al., 2016
heart anatomical region edematous, abnormal flt4um131/um131 standard conditions Fig. 6 with image from Shin et al., 2016
posterior caudal vein vascular sprouts decreased amount, abnormal flt4um131/um131 standard conditions Fig. 3 with image from Shin et al., 2016
swim bladder inflation decreased occurrence, abnormal flt4um131/um131 standard conditions Fig. 6 with image from Shin et al., 2016
digestive system anatomical region edematous, abnormal flt4um131/um131 standard conditions Fig. 6 with image from Shin et al., 2016
lateral facial lymph vessel lymphangiogenic sprout DsRed expression absent, abnormal flt4um131/um131 ; nz101Tg standard conditions Fig. 7 with image from Shin et al., 2016
otolithic lymph vessel absent, abnormal flt4um131/um131 ; nz101Tg standard conditions Fig. 7 with image from Shin et al., 2016
lateral facial lymph vessel lymphangiogenic sprout absent, abnormal flt4um131/um131 ; nz101Tg standard conditions Fig. 7 with image from Shin et al., 2016
otolithic lymph vessel DsRed expression absent, abnormal flt4um131/um131 ; nz101Tg standard conditions Fig. 7 with image from Shin et al., 2016
lateral facial lymph vessel truncated, abnormal flt4um131/um131 ; nz101Tg standard conditions Fig. 7 with image from Shin et al., 2016
lymphangiogenic sprout decreased amount, abnormal flt4um131/um131 ; y1Tg standard conditions Fig. 3 with image from Shin et al., 2016
lateral facial lymph vessel lymph vessel development process quality, abnormal flt4um131/um131 ; y1Tg standard conditions Fig. 7 with image from Shin et al., 2016
primordial hindbrain channel malformed, abnormal flt4um131/um131 ; y1Tg standard conditions Fig. 2 with image from Shin et al., 2016
primordial hindbrain channel absent, abnormal flt4um131/um131 ; y1Tg standard conditions Fig. 2 with image from Shin et al., 2016
thoracic duct lymph vessel development decreased occurrence, abnormal flt4um131/um131 ; y1Tg standard conditions Fig. 2 with image from Shin et al., 2016
lateral facial lymph vessel closed, abnormal flt4um131/um131 ; y1Tg standard conditions Fig. 7 with image from Shin et al., 2016
parachordal vessel absent, abnormal flt4um131/um131 ; y1Tg standard conditions Fig. 3 with image from Shin et al., 2016
intersegmental vein EGFP expression absent, abnormal flt4um131/um131 ; y1Tg standard conditions Fig. 3 with image from Shin et al., 2016
thoracic duct absent, abnormal flt4um131/um131 ; y1Tg standard conditions Fig. 2 with image from Shin et al., 2016
primordial hindbrain channel vasculature development decreased occurrence, abnormal flt4um131/um131 ; y1Tg standard conditions Fig. 2 with image from Shin et al., 2016
lateral facial lymph vessel malformed, abnormal flt4um131/um131 ; y1Tg standard conditions Fig. 7 with image from Shin et al., 2016
parachordal vessel vasculature development decreased occurrence, abnormal flt4um131/um131 ; y1Tg standard conditions Fig. 3 with image from Shin et al., 2016
thoracic duct lymph vessel development process quality, abnormal y1Tg ; flt4um131/+ standard conditions Fig. 2 with image from Shin et al., 2016
thoracic duct lymph vessel development decreased occurrence, abnormal y1Tg ; flt4um131/+ standard conditions Fig. 2 with image from Shin et al., 2016
thoracic duct malformed, abnormal y1Tg ; flt4um131/+ standard conditions Fig. 2 with image from Shin et al., 2016
Genome Resources:
CITATIONS (3)